Dianthus Therapeutics Inc. (DNTH) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-1.19x
Dianthus Therapeutics Inc. (DNTH) has a Cash Flow-to-Debt Ratio of -1.19x as of June 2026, meaning its operating cash flow of $-48.98 Million could theoretically repay -1% of its total liabilities ($41.25 Million) in one year. See Dianthus Therapeutics Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.19x
Operating CF / Total Liabilities
Operating Cash Flow
$-48.98 Million
USD
Total Liabilities
$41.25 Million
USD
Data as of
Jun 2026
Most recent filing
Dianthus Therapeutics Inc. Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Dianthus Therapeutics Inc. across 10 annual periods. For the full cash flow conversion analysis, see Dianthus Therapeutics Inc. operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Dianthus Therapeutics Inc. (2016–2025)
Year-by-year debt coverage analysis for Dianthus Therapeutics Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.44x | $-129.06 Million | $37.52 Million | ▲ +5.3% |
| 2024 | -3.63x | $-78.18 Million | $21.53 Million | ▼ -3.8% |
| 2023 | -3.50x | $-36.86 Million | $10.54 Million | ▼ -13.8% |
| 2022 | -3.07x | $-29.07 Million | $9.45 Million | ▲ +10.8% |
| 2021 | -3.45x | $-59.53 Million | $17.26 Million | ▲ +4.6% |
| 2020 | -3.61x | $-64.02 Million | $17.71 Million | ▼ -28.6% |
| 2019 | -2.81x | $-57.10 Million | $20.32 Million | ▲ +21.7% |
| 2018 | -3.59x | $-41.89 Million | $11.66 Million | ▲ +33.2% |
| 2017 | -5.37x | $-22.26 Million | $4.14 Million | ▼ -89.3% |
| 2016 | -2.84x | $-6.53 Million | $2.30 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.